韓國(guó)SD快速診斷試劑

韓國(guó)SD快速診斷試劑

【韓國(guó)SD快速診斷試劑】韓國(guó)SD自1999年成立至今，一直都在專注做快速診斷試劑，其產(chǎn)品質(zhì)量世界聞名，尤其是丙肝、瘧疾和艾滋病的快速診斷試劑都是通過(guò)WHO資格審批，并列入的采購(gòu)品牌，在世界IVD市場(chǎng)上占有一席之地。我司為韓國(guó)SD公司在中國(guó)地區(qū)戰(zhàn)略合作伙伴，負(fù)責(zé)該公司產(chǎn)品的總經(jīng)銷及售后服務(wù)工作。詳情可以我司工作人員。

（  MOB：楊永漢） 
 

【】

我司還提供其它進(jìn)口試劑盒：登革熱、瘧疾、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團(tuán)菌等ELISA方法的試劑盒、日本生研細(xì)菌分型診斷血清、德國(guó)SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。歡迎隨時(shí)咨詢我們。
【】SD has been in the development of rapid diagnostic tests, so that people can in the early stage diagnosis of various diseases, since its establishment in February 1999, SD vigorous development, has become a global leader in in vitro diagnostics, their main products, such as malaria, dengue fever, HIV and syphilis, is the world famous quality products. These products are supplied to more than 120 countries in the world through international organizations such as who, UNICEF, government procurement and overseas distributors. It has passed the WHO qualification approval products are: hepatitis C, malaria, AIDS detection reagents. It is the first ELISA kit developed in the world, and the world's first developed a rapid detection of dengue fever, rapid detection of influenza virus A / B (H1N1), and rapid test of avian influenza.

Alere group is a leading global health diagnostic products listed on the New York stock exchange and health diagnosis management solutions provider, headquartered in Waltham, Boston, United states. The company has world-class research capacity, production base and sales network, the world has more than 50 branches, nearly 20 thousand employees, as well as more than 800 R & D team. While focusing on product development and marketing operations, the group encompasses almost all diagnostic testing patents, including rapid analysis, testing technology, and medical sensors. Alere is the world POCT overlord, the global professional POCT market size of about $6 billion, accounting for about 60 billion of the $IVD market 10-11%. Alere's 2015 sales of about $2 billion 500 million, accounting for the entire POCT market share of more than 40%, is a well deserved boss.

二維碼掃一掃

【公司名稱】 廣州健侖生物科技有限公司
【】    楊永漢 

【】
【騰訊 】
【公司地址】 廣州清華科技園創(chuàng)新基地番禺石樓鎮(zhèn)創(chuàng)啟路63號(hào)二期2幢101-3室